|
|
Expression and significance of UCH-L1 and S100B protein in peripheral blood of children with epilepsy#br# |
ZHANG Shuang YAN Kai LI Shuhua ZHANG Jing JIA Yufeng |
Department of Paediatrics, Tangshan Maternal and Child Health Care Hospital, Hebei Province, Tangshan 063000,China |
|
|
Abstract Objective To observe the expression levels of serum ubiquitin carboxy-terminal hydrolase-l1 (UCH-L1) and S100B protein in peripheral blood of children with epilepsy and to explore its significance. Methods A total of 80 children with epilepsy who were newly diagnosed in Tangshan Maternal and Child Health Hospital of Hebei Province (hereinafter referred to as “our hospital”) from October 2018 to October 2019 and had seizure within 24 hours before admission were selected as the case group, and a total of 80 healthy children in our hospital were selected as the control group. Fasting venous blood was collected in the morning, and the serum UCH-L1 and S100B protein expression levels were detected by double-antibody sandwich enzyme-linked immunosorbent assay, and the serum UCH-L1 and S100B protein expression levels were compared among the children with different seizure duration and seizure types in the case group. Results UCH-L1 and S100B protein levels in the case group were significantly higher than those in the control group (P < 0.01). UCH-L1 and S100B protein levels in epilepsy duration ≥5 min group were higher than those in epilepsy duration < 5 min group (P < 0.05 or P < 0.01). UCH-L1 and S100B protein levels in generalized seizure group were significantly higher than those in focal seizure group (P < 0.01). Conclusion UCH-L1 and S100B protein levels in the peripheral blood of children with epilepsy are increased, and the increase of both is related to the duration and type of epileptic seizure.
|
|
|
|
|
[1] 王卫平.儿科学[M].北京:人民卫生出版社,2018:367.
[2] 许蓓,陈强,周洋,等.学龄期原发性癫痫儿童身心健康状况评估[J].中国医药导报,2018,15(9):81-84.
[3] Thom M,Boldrini M,Bundock E,et al. The past,present and future challenges in epilepsy related and sudden deaths and biobanking [J]. Neuropathol Appl Neurobiol,2018,44(1):32-55.
[4] 梁锦平.国际抗癫痫联盟2017年版癫痫分类特点及其解读[J].中国实用儿科杂志,2020,35(1):47-54.
[5] 秦龙,黄书岚,邢泽刚.UCH-L1在癫痫患者脑脊液和血液中的表达及意义[J].中国临床神经外科杂志,2013,18(9):547-549.
[6] 梁锦平.国际抗癫痫联盟新修订发作类型操作性分类的特征及解读[J].中华神经科杂志,2019,52(1):71-78.
[7] 李若松,王尊升,刘伟峰,等.基于衰减皮尔森相关的癫痫脑网络动态分析方法[J].北京生物医学工程,2019,38(5):457-464.
[8] Wallace RH,Scheffer IE,Parasuvam G,et al. Generalized epilepsy with febrile seizures plus:Mutation of the sodium channel subunit SCN1B [J]. Neurology,2016,58(9):1426-1429.
[9] Ngugi AK,Bottomley C,Fegan G,et al. Premature mortality in active convulsive epilepsy in rural Kenya:Causes and associated factors [J]. Neurology,2016,82(7):582-589.
[10] Catterall WA. From ioniccurrents to molecular mechanisms:The structure and function of voltage-gated sodium channels [J]. Neuron,2015,26(1):13-25.
[11] Ramezani F,Bahrami-Amiri A,Babahajian A,et al. Ubiquitin C-Terminal Hydrolase-L1(UCH-L1)in prediction of computed tomography findings in traumatic brain injury; a Meta-Analysis [J]. Emerg(Tehran),2018, 6(1):e62.
[12] 余前,王璐,杨平来,等.重型脑损伤患者血清UCH-L1、Caspase-3水平变化及其临床意义[J]. 山东医药,2020, 60(34):24-28.
[13] 王佳,张红玉,杜鹏,等.血清UCH-L1与NGAL对重度脑损伤患者的病情及短期预后的评估价值[J].标记免疫分析与临床,2020,27(2):195-199,205.
[14] 袁雪松,卞晓星.S100B蛋白及其在颅脑损伤中的临床作用[J].临床外科杂志,2007,15(4):274-276.
[15] 杨智全,王海青,支更花,等.外周血UCH-L1、NSE表达水平对热性惊厥患儿脑损伤及预后的评估价值[J].临床和实验医学杂志,2020,19(2):162-164.
[16] Asadollahi M,Simani L. The diagnostic value of serum UCHL-1 and S100-B levels in differentiate epileptic seizures from psychogenic attacks [J]. Brain Res,2019, 1704:11-15.
[17] 魏志玄.大鼠癫痫模型脑脊液中S100B水平测定[J].中国医学工程,2014,22(1):20.
[18] 何金婷,李晓炎,邱培森,等.S100B与神经系统疾病相关性研究进展[J].中国实验诊断学,2019,23(9):1650-1654.
[19] 刘润宁.早期早产儿脐血中S100B蛋白及肌酸激酶脑型同工酶的临床意义[J].中国妇幼保健,2019,34(2):337-339.
[20] 黄小玲,林跃清,周冰新,等.血清S100B蛋白在新生儿缺氧缺血性脑病中的应用[J].中国当代医药,2020, 27(30):82-85.
[21] Celikbilek A,Akyol L,Sabah S,et al. S100B as a glial cell marker in diabetic peripheral neuropathy [J]. Neurosci Lett,2013,558 (1):53-57.
[22] Seifert G,Steinhauser C. Neuron-astrocyte signaling and epilepsy [J]. Exp Neurol,2013,244:4-10.
[23] Liang KG,Mu RZ,Liu Y,et al. Increased Serum S100B Levels in Patients With Epilepsy:A Systematic Review and Meta-Analysis Study [J]. Front Neurosci,2019,13:456.
[24] 徐建洋,陈刚,肖成华,等.癫痫患者与假性发作患者血清S100B蛋白、超敏C反应蛋白和神经元特异性烯醇化酶水平的改变及其意义[J].临床神经病学杂志,2012, 25(2):27-29.
[25] 郑凤丽,黎素清,谭志军,等.C反应蛋白、S100B蛋白和神经元特异性烯醇化酶水平与小儿癫痫之间的相关性分析[J].国际检验医学杂志,2019,40(19):2344-2347.
[26] Chmielewska N,Szyndler J,Makowska K,et al. Looking for novel,brain derived,peripheral biomarkers of neurological disorders [J]. Neurol Neurochir Pol,2018,52(3):318-325.
[27] Li Y,Wang Z,Zhang B,et al. Cerebrospinal fluid ubiquitin C-terminal hydrolase as a novel marker of neuronal damage after epileptic seizure [J]. Epilepsy Res,2013, 103(2/3):205-210.
[28] 郝伟红,姜红,马慧平.S100B蛋白、BDNF、IGF-1在癫痫婴儿血清中的水平及临床意义[J].中国临床研究,2017, 30(9):1186-1188.
[29] 刘迪辉,罗向阳,邓向红.S100B蛋白在癫痫患儿中的表达及意义[J].神经病学与神经康复学杂志,2011,8(3):122-124. |
|
|
|